688578.SH
艾力斯
SSE · Healthcare · Biotechnology · CN
CNY 112.19
−3.70%Margins
Gross margin
96.3%
EBITDA margin
46.3%
EBIT margin
50.3%
Net margin
42.6%
FCF margin
41.4%
31.2%
Return on equity
28.1%
Return on assets
36.9%
Return on invested capital
0.69x
Asset turnover
CNY 2.5B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026